DZ3159A1 - Derives de purine. - Google Patents

Derives de purine.

Info

Publication number: DZ3159A1
Authority: DZ; Algeria
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-10-14

Application number

DZ003159A

Other languages

English (en)

French (fr)

Inventor

Sandra Marina Monaghan

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-14

Filing date

2000-10-06

Publication date

2001-04-19

2000-10-06 Application filed by Pfizer filed Critical Pfizer

2001-04-19 Application granted granted Critical

2001-04-19 Publication of DZ3159A1 publication Critical patent/DZ3159A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Hematology (AREA)
Oncology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)

DZ003159A 1999-10-14 2000-10-06 Derives de purine. DZ3159A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9924363.6A GB9924363D0 (en)	1999-10-14	1999-10-14	Purine derivatives
IB0011444		2000-10-06

Publications (1)

Publication Number	Publication Date
DZ3159A1 true DZ3159A1 (fr)	2001-04-19

Family

ID=10862760

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003159A DZ3159A1 (fr)	1999-10-14	2000-10-06	Derives de purine.

Country Status (50)

Country	Link
US (1)	US6350735B1 (xx)
EP (1)	EP1220863B1 (xx)
JP (1)	JP3994007B2 (xx)
KR (1)	KR20020037774A (xx)
CN (1)	CN1151167C (xx)
AP (1)	AP1442A (xx)
AR (1)	AR023275A1 (xx)
AT (1)	ATE238336T1 (xx)
AU (1)	AU768308B2 (xx)
BG (1)	BG106569A (xx)
BR (1)	BR0011776A (xx)
CA (1)	CA2387531C (xx)
CO (1)	CO5251399A1 (xx)
CR (1)	CR6584A (xx)
CZ (1)	CZ20021223A3 (xx)
DE (1)	DE60002356T2 (xx)
DK (1)	DK1220863T3 (xx)
DZ (1)	DZ3159A1 (xx)
EA (1)	EA004655B1 (xx)
EC (1)	ECSP003712A (xx)
EE (1)	EE200200193A (xx)
ES (1)	ES2193990T3 (xx)
GB (1)	GB9924363D0 (xx)
GE (1)	GEP20043269B (xx)
GT (1)	GT200000172A (xx)
HK (1)	HK1047110B (xx)
HN (1)	HN2000000204A (xx)
HU (1)	HUP0203483A2 (xx)
IL (1)	IL146342A0 (xx)
IS (1)	IS6165A (xx)
MA (1)	MA26828A1 (xx)
MX (1)	MXPA02003812A (xx)
MY (1)	MY136242A (xx)
NO (1)	NO20021692D0 (xx)
NZ (1)	NZ515323A (xx)
OA (1)	OA12059A (xx)
PA (1)	PA8503501A1 (xx)
PE (1)	PE20010755A1 (xx)
PL (1)	PL354932A1 (xx)
PT (1)	PT1220863E (xx)
SI (1)	SI1220863T1 (xx)
SK (1)	SK4842002A3 (xx)
SV (1)	SV2002000198A (xx)
TN (1)	TNSN00202A1 (xx)
TR (1)	TR200200985T2 (xx)
UA (1)	UA66945C2 (xx)
UY (1)	UY26397A1 (xx)
WO (1)	WO2001027130A1 (xx)
YU (1)	YU88901A (xx)
ZA (1)	ZA200202849B (xx)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7427606B2 (en) *	1999-02-01	2008-09-23	University Of Virginia Patent Foundation	Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) *	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
WO2002096462A1 (en) *	2001-05-25	2002-12-05	Pfizer Inc.	An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases
JP4514452B2 (ja) *	2001-10-01	2010-07-28	ユニバーシティオブバージニアパテントファウンデーション	Ａ２ａアゴニスト活性を有する２−プロピルアデノシン・アナログおよびその組成物
US20090170803A1 (en) *	2002-04-10	2009-07-02	Linden Joel M	Adjunctive treatment of biological diseases
AR044519A1 (es)	2003-05-02	2005-09-14	Novartis Ag	Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
US20050033044A1 (en)	2003-05-19	2005-02-10	Bristol-Myers Squibb Pharma Company	Methods for preparing 2-alkynyladenosine derivatives
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
US7442687B2 (en) *	2004-08-02	2008-10-28	The University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
US7576069B2 (en) *	2004-08-02	2009-08-18	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
WO2006015357A2 (en) *	2004-08-02	2006-02-09	University Of Virginia Patent Foundation	2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
EP1893593A1 (en) *	2005-06-15	2008-03-05	Pfizer Limited	3-phenylazetidine derivatives as dopamine agonists
CN100352823C (zh) *	2005-08-19	2007-12-05	浙江车头制药有限公司	一种腺嘌呤衍生物的制备方法
EP1957530A2 (en)	2005-10-21	2008-08-20	Novartis AG	Human antibodies against il13 and therapeutic uses
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
US20080027022A1 (en) *	2006-02-08	2008-01-31	Linden Joel M	Method to treat gastric lesions
WO2007120972A2 (en)	2006-02-10	2007-10-25	University Of Virginia Patent Foundation	Method to treat sickle cell disease
US8188063B2 (en) *	2006-06-19	2012-05-29	University Of Virginia Patent Foundation	Use of adenosine A2A modulators to treat spinal cord injury
EP2081933B1 (en)	2006-09-29	2011-03-23	Novartis AG	Pyrazolopyrimidines as pi3k lipid kinase inhibitors
MX2009004715A (es)	2006-10-30	2009-05-20	Novartis Ag	Compuestos heterociclicos como agentes antiinflamatorios.
US8058259B2 (en) *	2007-12-20	2011-11-15	University Of Virginia Patent Foundation	Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
JP5584138B2 (ja)	2008-01-11	2014-09-03	ノバルティスアーゲー	キナーゼ阻害剤としてのピリミジン類
US20110281917A1 (en)	2009-01-29	2011-11-17	Darrin Stuart	Substituted Benzimidazoles for the Treatment of Astrocytomas
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
EA201200260A1 (ru)	2009-08-12	2012-09-28	Новартис Аг	Гетероциклические гидразоны и их применение для лечения рака и воспаления
AU2010284254B2 (en)	2009-08-17	2015-09-17	Intellikine, Llc	Heterocyclic compounds and uses thereof
EA201200318A1 (ru)	2009-08-20	2012-09-28	Новартис Аг	Гетероциклические оксимы
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
US20130324526A1 (en)	2011-02-10	2013-12-05	Novartis Ag	[1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
WO2012116237A2 (en)	2011-02-23	2012-08-30	Intellikine, Llc	Heterocyclic compounds and uses thereof
AU2012220572A1 (en)	2011-02-25	2013-08-29	Irm Llc	Compounds and compositions as trk inhibitors
EA026655B1 (ru)	2011-09-15	2017-05-31	Новартис Аг	6-ЗАМЕЩЕННЫЕ 3-(ХИНОЛИН-6-ИЛТИО)[1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ c-MET ТИРОЗИНКИНАЗЫ
JP6130391B2 (ja)	2011-11-23	2017-05-17	インテリカイン，エルエルシー	Ｍｔｏｒ阻害剤を使用する強化された治療レジメン
US20150297604A1 (en)	2012-04-03	2015-10-22	Novartis Ag	Combination Products with Tyrosine Kinase Inhibitors and their Use
CN105246482A (zh)	2013-03-15	2016-01-13	因特利凯有限责任公司	激酶抑制剂的组合及其用途
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
JP6526789B2 (ja)	2014-07-31	2019-06-05	ノバルティスアーゲー	組み合わせ療法
CA3102279A1 (en)	2018-06-01	2019-12-05	Cornell University	Combination therapy for pi3k-associated disease or disorder
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en) *	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
AU8276187A (en) *	1986-10-31	1988-05-25	Warner-Lambert Company	Selected n6-substituted adenosines having selective a2 binding activity
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5877180A (en) *	1994-07-11	1999-03-02	University Of Virginia Patent Foundation	Method for treating inflammatory diseases with A2a adenosine receptor agonists
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
BR9914526A (pt) *	1998-10-16	2001-07-03	Pfizer	Derivados de adenina

1999
- 1999-10-14 GB GBGB9924363.6A patent/GB9924363D0/en not_active Ceased
2000
- 2000-09-14 HN HN2000000204A patent/HN2000000204A/es unknown
- 2000-09-26 PA PA20008503501A patent/PA8503501A1/es unknown
- 2000-10-06 CN CNB008096287A patent/CN1151167C/zh not_active Expired - Fee Related
- 2000-10-06 CA CA002387531A patent/CA2387531C/en not_active Expired - Fee Related
- 2000-10-06 BR BR0011776-5A patent/BR0011776A/pt not_active IP Right Cessation
- 2000-10-06 DK DK00964566T patent/DK1220863T3/da active
- 2000-10-06 AU AU75488/00A patent/AU768308B2/en not_active Ceased
- 2000-10-06 CZ CZ20021223A patent/CZ20021223A3/cs unknown
- 2000-10-06 HU HU0203483A patent/HUP0203483A2/hu unknown
- 2000-10-06 ES ES00964566T patent/ES2193990T3/es not_active Expired - Lifetime
- 2000-10-06 HK HK02108605.8A patent/HK1047110B/zh not_active IP Right Cessation
- 2000-10-06 JP JP2001530348A patent/JP3994007B2/ja not_active Expired - Fee Related
- 2000-10-06 AP APAP/P/2002/002478A patent/AP1442A/en active
- 2000-10-06 EE EEP200200193A patent/EE200200193A/xx unknown
- 2000-10-06 YU YU88901A patent/YU88901A/sh unknown
- 2000-10-06 DZ DZ003159A patent/DZ3159A1/xx active
- 2000-10-06 DE DE60002356T patent/DE60002356T2/de not_active Expired - Fee Related
- 2000-10-06 MX MXPA02003812A patent/MXPA02003812A/es active IP Right Grant
- 2000-10-06 EP EP00964566A patent/EP1220863B1/en not_active Expired - Lifetime
- 2000-10-06 WO PCT/IB2000/001444 patent/WO2001027130A1/en not_active Ceased
- 2000-10-06 SI SI200030102T patent/SI1220863T1/xx unknown
- 2000-10-06 TR TR2002/00985T patent/TR200200985T2/xx unknown
- 2000-10-06 NZ NZ515323A patent/NZ515323A/en unknown
- 2000-10-06 GE GEAP20006243A patent/GEP20043269B/en unknown
- 2000-10-06 KR KR1020027004748A patent/KR20020037774A/ko not_active Abandoned
- 2000-10-06 UA UA2002042943A patent/UA66945C2/uk unknown
- 2000-10-06 AT AT00964566T patent/ATE238336T1/de not_active IP Right Cessation
- 2000-10-06 OA OA1200200102A patent/OA12059A/en unknown
- 2000-10-06 EA EA200101107A patent/EA004655B1/ru not_active IP Right Cessation
- 2000-10-06 PT PT00964566T patent/PT1220863E/pt unknown
- 2000-10-06 PL PL00354932A patent/PL354932A1/xx not_active Application Discontinuation
- 2000-10-06 IL IL14634200A patent/IL146342A0/xx unknown
- 2000-10-06 SK SK484-2002A patent/SK4842002A3/sk unknown
- 2000-10-12 CO CO00077985A patent/CO5251399A1/es not_active Application Discontinuation
- 2000-10-12 MY MYPI20004790A patent/MY136242A/en unknown
- 2000-10-12 EC EC2000003712A patent/ECSP003712A/es unknown
- 2000-10-12 GT GT200000172A patent/GT200000172A/es unknown
- 2000-10-13 UY UY26397A patent/UY26397A1/es not_active Application Discontinuation
- 2000-10-13 AR ARP000105421A patent/AR023275A1/es unknown
- 2000-10-13 SV SV2000000198A patent/SV2002000198A/es unknown
- 2000-10-13 TN TNTNSN00202A patent/TNSN00202A1/fr unknown
- 2000-10-13 PE PE2000001098A patent/PE20010755A1/es not_active Application Discontinuation
- 2000-10-16 US US09/688,624 patent/US6350735B1/en not_active Expired - Fee Related
2001
- 2001-11-16 IS IS6165A patent/IS6165A/is unknown
2002
- 2002-02-08 CR CR6584A patent/CR6584A/es not_active Application Discontinuation
- 2002-04-02 BG BG106569A patent/BG106569A/xx unknown
- 2002-04-09 MA MA26590A patent/MA26828A1/fr unknown
- 2002-04-10 NO NO20021692A patent/NO20021692D0/no not_active Application Discontinuation
- 2002-04-11 ZA ZA200202849A patent/ZA200202849B/xx unknown

Also Published As

Publication number	Publication date
MA26828A1 (fr)	2004-12-20
CN1358192A (zh)	2002-07-10
HN2000000204A (es)	2001-06-21
HUP0203483A2 (hu)	2003-02-28
DE60002356T2 (de)	2004-02-19
BG106569A (en)	2002-12-29
CO5251399A1 (es)	2003-02-28
AU7548800A (en)	2001-04-23
ES2193990T3 (es)	2003-11-16
IS6165A (is)	2001-11-16
EE200200193A (et)	2003-06-16
CA2387531A1 (en)	2001-04-19
GT200000172A (es)	2002-04-05
NZ515323A (en)	2003-10-31
EP1220863B1 (en)	2003-04-23
MXPA02003812A (es)	2002-09-30
CR6584A (es)	2004-01-14
MY136242A (en)	2008-08-29
AP2002002478A0 (en)	2002-06-30
CN1151167C (zh)	2004-05-26
NO20021692L (no)	2002-04-10
DK1220863T3 (da)	2003-08-11
TNSN00202A1 (fr)	2005-11-10
ATE238336T1 (de)	2003-05-15
GEP20043269B (en)	2004-06-25
DE60002356D1 (de)	2003-05-28
NO20021692D0 (no)	2002-04-10
YU88901A (sh)	2004-09-03
AU768308B2 (en)	2003-12-04
IL146342A0 (en)	2002-07-25
UA66945C2 (uk)	2004-06-15
SV2002000198A (es)	2002-02-05
EA200101107A1 (ru)	2002-10-31
KR20020037774A (ko)	2002-05-22
JP2003511459A (ja)	2003-03-25
JP3994007B2 (ja)	2007-10-17
EA004655B1 (ru)	2004-06-24
US6350735B1 (en)	2002-02-26
ZA200202849B (en)	2003-06-25
PL354932A1 (en)	2004-03-22
PT1220863E (pt)	2003-07-31
CA2387531C (en)	2006-12-05
AP1442A (en)	2005-06-29
UY26397A1 (es)	2001-05-31
EP1220863A1 (en)	2002-07-10
OA12059A (en)	2006-05-03
PA8503501A1 (es)	2002-02-21
BR0011776A (pt)	2002-03-12
GB9924363D0 (en)	1999-12-15
TR200200985T2 (tr)	2002-10-21
ECSP003712A (es)	2002-05-23
AR023275A1 (es)	2002-09-04
CZ20021223A3 (cs)	2003-05-14
SI1220863T1 (en)	2003-10-31
SK4842002A3 (en)	2003-06-03
PE20010755A1 (es)	2001-07-17
HK1047110A1 (en)	2003-02-07
HK1047110B (zh)	2005-03-04
WO2001027130A1 (en)	2001-04-19

Publication	Publication Date	Title
DZ3159A1 (fr)	2001-04-19	Derives de purine.
MA26799A1 (fr)	2004-12-20	Derives de purine
MA26832A1 (fr)	2004-12-20	Derives de benzodiazepine.
ATE321065T1 (de)	2006-04-15	Purin-derivate
MA26918A1 (fr)	2004-12-20	Derives de purine
TR200000520A3 (tr)	2001-06-21	4-Fenil-piridin türevleri.
DZ3439A1 (fr)	2001-12-13	Derives de 2-aminocarbonyl-9h-purine
MA26794A1 (fr)	2004-12-20	Derives de 5-phenyl-pyrimidine.
NO20010743D0 (no)	2001-02-14	Antivirale indoloksoacetyl-piperazin-derivater
ATE325807T1 (de)	2006-06-15	Purinderivate
FR2810318B1 (fr)	2005-09-23	Derives de diamano-phenothiazine
PT1154988E (pt)	2004-12-31	Derivados de mevinolina
MA26793A1 (fr)	2004-12-20	Derives de 4-phenyl-pyrimidine.
MA26967A1 (fr)	2004-12-20	Derives de pyrimidine
PT1088818E (pt)	2005-03-31	Derivados de quinolin-4-ilo
PT1194401E (pt)	2004-02-27	Derivados de diacil-hidrazina
EP1240156A4 (en)	2003-04-16	3-METHYL CHROME OR THIOCHROME DERIVATIVES
DK1090019T3 (da)	2005-02-07	Adenosinderivater
ES1044710Y (es)	2000-10-16	Cenicero perfeccionado.